Legal & General Group
EXAS

Legal & General Group’s Exact Sciences EXAS Stock Holding History

Legal & General Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-312,104
Closed -$31.7M – 3382
2025
Q4 		$31.7M Sell
312,104
-25,308
-8% -$2.03M 0.01% 715
2025
Q3 		$18.5M Sell
337,412
-6,657
-2% -$333K ﹤0.01% 901
2025
Q2 		$18.3M Sell
344,069
-91,562
-21% -$4.65M ﹤0.01% 886
2025
Q1 		$18.9M Sell
435,631
-25,977
-6% -$1.32M 0.01% 831
2024
Q4 		$25.9M Sell
461,608
-24,498
-5% -$1.52M 0.01% 757
2024
Q3 		$33.1M Sell
486,106
-320,184
-40% -$18.1M 0.01% 700
2024
Q2 		$34.1M Sell
806,290
-52,926
-6% -$2.91M 0.01% 686
2024
Q1 		$59.3M Sell
859,216
-22,863
-3% -$1.45M 0.02% 593
2023
Q4 		$65.3M Sell
882,079
-78,130
-8% -$5.12M 0.02% 569
2023
Q3 		$65.5M Sell
960,209
-17,064
-2% -$1.45M 0.02% 559
2023
Q2 		$91.8M Buy
977,273
+81,897
+9% +$6.39M 0.03% 502
2023
Q1 		$60.7M Sell
895,376
-82,418
-8% -$5.3M 0.02% 582
2022
Q4 		$48.4M Sell
977,794
-160,225
-14% -$6.55M 0.02% 633
2022
Q3 		$37M Sell
1,138,019
-16,377
-1% -$675K 0.01% 681
2022
Q2 		$45.5M Buy
1,154,396
+12,231
+1% +$654K 0.02% 656
2022
Q1 		$79.9M Buy
1,142,165
+99,410
+10% +$7.27M 0.02% 583
2021
Q4 		$81.2M Sell
1,042,755
-18,924
-2% -$1.67M 0.02% 581
2021
Q3 		$101M Buy
1,061,679
+12,340
+1% +$1.3M 0.03% 533
2021
Q2 		$130M Buy
1,049,339
+183,067
+21% +$21.8M 0.04% 453
2021
Q1 		$114M Buy
866,272
+12,608
+1% +$1.73M 0.04% 460
2020
Q4 		$113M Buy
853,664
+35,678
+4% +$4.31M 0.04% 440
2020
Q3 		$83.4M Sell
817,986
-2,264
-0.3% -$196K 0.04% 468
2020
Q2 		$71.3M Buy
820,250
+18,575
+2% +$1.48M 0.03% 481
2020
Q1 		$46.7M Buy
801,675
+32,503
+4% +$2.64M 0.03% 529
2019
Q4 		$71.1M Buy
769,172
+102,745
+15% +$9.03M 0.03% 514
2019
Q3 		$60.2M Buy
666,427
+321,012
+93% +$36.6M 0.03% 532
2019
Q2 		$40.8M Buy
345,415
+250,938
+266% +$25.3M 0.02% 623
2019
Q1 		$8.18M Buy
94,477
+33,235
+54% +$2.83M ﹤0.01% 950
2018
Q4 		$3.87M Buy
61,242
+5,080
+9% +$349K ﹤0.01% 1213
2018
Q3 		$4.43M Buy
56,162
+8
+0% +$522 ﹤0.01% 1251
2018
Q2 		$3.36M Buy
56,154
+5,312
+10% +$286K ﹤0.01% 1367
2018
Q1 		$2.05M Sell
50,842
-3,776
-7% -$184K ﹤0.01% 1604
2017
Q4 		$2.89M Buy
54,618
+4,181
+8% +$223K ﹤0.01% 1415
2017
Q3 		$2.37M Buy
50,437
+8,101
+19% +$326K ﹤0.01% 1486
2017
Q2 		$1.5M Buy
42,336
+6,273
+17% +$194K ﹤0.01% 1671
2017
Q1 		$847K Sell
36,063
-461
-1% -$9.13K ﹤0.01% 1851
2016
Q4 		$490K Buy
36,524
+15,492
+74% +$250K ﹤0.01% 1985
2016
Q3 		$381K Sell
21,032
-134
-0.6% -$2.36K ﹤0.01% 1831
2016
Q2 		$247K Hold
21,166
– – ﹤0.01% 1691
2016
Q1 		$140K Buy
21,166
+3,881
+22% +$24.8K ﹤0.01% 1868
2015
Q4 		$157K Hold
17,285
– – ﹤0.01% 1850
2015
Q3 		$316K Buy
17,285
+983
+6% +$22.6K ﹤0.01% 1470
2015
Q2 		$479K Buy
16,302
+1,107
+7% +$27.8K ﹤0.01% 1325
2015
Q1 		$341K Buy
15,195
+2,934
+24% +$74.4K ﹤0.01% 1419
2014
Q4 		$353K Sell
12,261
-592
-5% -$14.4K ﹤0.01% 1329
2014
Q3 		$249K Buy
+12,853
New +$236K ﹤0.01% 1401

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Legal & General Group's EXAS Position: Q1 2026 in Review

Legal & General Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 312,104 shares — an estimated $31.7M sold.

Legal & General Group first reported a position in EXAS in Q3 2014 and held it in 46 quarters. The position peaked at $130M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Legal & General Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Legal & General Group sold 312,104 Exact Sciences shares in Q1 2026, an estimated $31.7M.
  • Legal & General Group first reported a position in Exact Sciences in Q3 2014 and held it in 46 quarters.
  • Legal & General Group's Exact Sciences position peaked at $130M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.